.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Baxter
Federal Trade Commission
Novartis
Julphar
Deloitte
Healthtrust
Moodys
AstraZeneca
Cantor Fitzgerald

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020273

« Back to Dashboard
NDA 020273 describes DOVONEX, which is a drug marketed by Leo Pharm and Leo Pharma As and is included in three NDAs. It is available from four suppliers. Additional details are available on the DOVONEX profile page.

The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.

Summary for NDA: 020273

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Dermatological Agents

Suppliers and Packaging for NDA: 020273

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOVONEX
calcipotriene
OINTMENT;TOPICAL 020273 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-878 66993-878-61 100 CARTON in 1 CASE (66993-878-61) > 1 TUBE in 1 CARTON > 60 g in 1 TUBE
DOVONEX
calcipotriene
OINTMENT;TOPICAL 020273 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-878 66993-878-78 50 CARTON in 1 CASE (66993-878-78) > 1 TUBE in 1 CARTON > 120 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;TOPICALStrength0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 29, 1993TE:RLD:Yes

Expired Orange Book Patents for NDA: 020273

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As
DOVONEX
calcipotriene
OINTMENT;TOPICAL020273-001Dec 29, 19934,866,048► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
US Army
Cipla
Cerilliant
Federal Trade Commission
US Department of Justice
Argus Health
Medtronic
Chubb
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot